title: Discontinued drugs in 2011: cardiovascular drugs.
abstract: This perspective is part of an annual series of papers discussing drugs dropped from development in the previous year. Specifically, this paper focuses on the 19 cardiovascular drugs discontinued in 2011 after reaching preclinical or Phase I - III clinical trials. Information for this perspective is mainly derived from a search of Pharmaprojects.
authors: China Pharmaceutical University, Center for Instrumental Analysis, Key Laboratory of Drug Quality Control & Pharmacovigilance, Ministry of Education, Nanjing, Jiangsu, People's Republic of China.
authors: Hong-Ping
authors: HP
authors: Zhao
authors: Hong-Min
authors: HM
authors: Jiang
authors: Bing-Ren
authors: BR
authors: Xiang
mesh_terms: D002317:Cardiovascular Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D017277:Drug Approval; D015507:Drugs, Investigational / Q000627:therapeutic use; D006801:Humans
chemical_list: D002317:Cardiovascular Agents; D015507:Drugs, Investigational